Literature DB >> 11863121

Minimal change disease in systemic lupus erythematosus.

G K Dube1, G S Markowitz, J Radhakrishnan, G B Appel, V D D'Agati.   

Abstract

We report the clinical and pathologic findings in 7 patients with systemic lupus erythematosus and minimal change disease. All 7 patients presented with full nephrotic syndrome including peripheral edema, nephrotic range proteinuria (mean 9.6 g/day), and hypoalbuminemia (mean 1.8 g/dl). In all cases, renal biopsy revealed diffuse foot process effacement in the absence of significant peripheral capillary wall immune deposits, findings consistent with minimal-change disease. In addition, 5 cases displayed mesangial electron-dense deposits, with or without associated mesangial proliferation, consistent with underlying lupus nephritis class II. In all cases, steroid therapy induced a rapid remission of nephrotic syndrome. Minimal change disease is an underrecognized and readily reversible form of nephrotic syndrome in systemic lupus erythematosus. Because it may occur superimposed on mild mesangial proliferative lupus nephritis, this entity may be misinterpreted as an atypical presentation of lupus nephritis class II. Proper recognition of this entity requires careful integration of the renal biopsy immunofluorescence and electron microscopic findings.

Entities:  

Mesh:

Year:  2002        PMID: 11863121     DOI: 10.5414/cnp57120

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  22 in total

Review 1.  Immunopathology of lupus nephritis.

Authors:  Hans-Joachim Anders; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

Review 2.  The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions.

Authors:  Suzanne Wilhelmus; Charles E Alpers; H Terence Cook; Franco Ferrario; Agnes B Fogo; Mark Haas; Kensuke Joh; Laure-Hélène Noël; Surya V Seshan; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 10.121

3.  A Pregnant Woman with Lupus and Nephrotic-Range Proteinuria.

Authors:  Andrew S Bomback
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-04       Impact factor: 8.237

Review 4.  Lupus podocytopathy: a distinct entity of lupus nephritis.

Authors:  Duqun Chen; Weixin Hu
Journal:  J Nephrol       Date:  2017-12-22       Impact factor: 3.902

5.  Lupus Podocytopathy: A Distinct Entity.

Authors:  Andrew S Bomback; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-16       Impact factor: 8.237

Review 6.  Recent advances in the treatment of lupus nephritis.

Authors:  Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-11-08       Impact factor: 2.801

7.  A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.

Authors:  Young Hoon Hong; Dae Young Yun; Yong Wook Jung; Myung Jin Oh; Hyun Je Kim; Choong Ki Lee
Journal:  Korean J Intern Med       Date:  2011-11-28       Impact factor: 2.884

8.  Clinical-Morphological Features and Outcomes of Lupus Podocytopathy.

Authors:  Weixin Hu; Yinghua Chen; Shaofan Wang; Hao Chen; Zhengzhao Liu; Caihong Zeng; Haitao Zhang; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-16       Impact factor: 8.237

Review 9.  An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.

Authors:  Alice S Appel; Gerald B Appel
Journal:  Nat Clin Pract Nephrol       Date:  2009-01-27

Review 10.  Pure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome.

Authors:  Guillermo Delgado-García; Carlos Cámara-Lemarroy; Adrián Infante-Valenzuela; Perla Colunga-Pedraza; Gabriela Alarcón-Galván; Arian Armenta-González; Héctor Jorge Villarreal-Velázquez
Journal:  Clin Rheumatol       Date:  2015-09-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.